SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $167.15 and last traded at $166.85, with a volume of 2785309 shares changing hands. The stock had previously closed at $160.11.
SPDR S&P Biotech ETF Stock Performance
The stock has a 50 day moving average price of $153.35 and a 200 day moving average price of $137.49. The company has a market cap of $10.67 billion, a P/E ratio of 11.47 and a beta of 0.83.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the company. Wealth Management Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 1st quarter valued at $547,000. Keystone Investors PTE Ltd. acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $12,022,000. Mirae Asset Global Investments Co. Ltd. lifted its stake in SPDR S&P Biotech ETF by 106.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,570 shares of the exchange traded fund’s stock valued at $3,240,000 after buying an additional 13,729 shares in the last quarter. Lalia Capital LLC purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $12,193,000. Finally, Jessup Wealth Management Inc acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $1,053,000.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
